A Number Of Actionable Events For XenoPort, With Capital To Back Up The … – Seeking Alpha

by admin on March 12, 2013

A Number Of Actionable Events For XenoPort, With Capital To Back Up The
Seeking Alpha
Horizant is XenoPort's FDA approved treatment for Restless Leg Syndrome (RLS), and up until 3Q of last year, it was being commercialized by GlaxoSmithKline (GSK). You can read details in PropThink's prior report, but following a lawsuit against the

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: